Focal Point on Genomic Medicine in Korea

Genomic medicine is taking off in South Korea in a big way, thanks in large part to innovative startups and systems for collecting and analyzing big data.

Single-cell sequencing, which enhances the accuracy of precision oncology therapies, is becoming accessible for clinical use in South Korea.

Researchers at Gangnam Severance Cancer Hospital in South Korea are improving the detection and interpretation of cancer mutations.

Easy-to-perform liquid biopsies promise to detect cancer earlier and enable doctors to more easily monitor response to treatment.

A big-data project and one of the world’s biggest biobanks will be invaluable resources at the Korea National Institute of Health.

A database of genomic variations will greatly improve the search for disease-associated genetic mutations in Asian populations.